Sandrine Guis Selected Research

Anti-Idiotypic Antibodies

4/2010

Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sandrine Guis Research Topics

Disease

7	Rheumatoid Arthritis 01/2017 - 03/2005
3	Psoriatic Arthritis 11/2023 - 01/2015
3	Arthritis (Polyarthritis) 01/2015 - 01/2009
2	Infections 01/2009 - 01/2006
2	Discitis 05/2004 - 01/2002
1	Muscular Diseases (Myopathy) 08/2023
1	COVID-19 10/2020
1	Pneumonia (Pneumonitis) 10/2020
1	Skin Neoplasms (Skin Cancer) 01/2020
1	Osteoporosis 01/2020
1	Neoplasms (Cancer) 01/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018
1	Spondylarthropathies 01/2018
1	Virus Diseases (Viral Diseases) 01/2018
1	Crohn Disease (Crohn's Disease) 01/2018
1	Skin Diseases (Skin Disease) 01/2018
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2017
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 08/2016
1	Breast Neoplasms (Breast Cancer) 08/2016
1	Inflammation (Inflammations) 01/2016
1	Arthralgia (Joint Pain) 12/2012
1	Back Pain (Backache) 12/2012
1	Uveitis 12/2012
1	Systemic Scleroderma (Systemic Sclerosis) 04/2010
1	Hepatitis B 01/2009
1	Necrosis 01/2009
1	Pseudolymphoma 07/2008
1	Myositis (Idiopathic Inflammatory Myopathies) 08/2006
1	Osteomyelitis 01/2006
1	Endocarditis 05/2004
1	Sepsis (Septicemia) 05/2004
1	Macrophagic myofasciitis 09/2002
1	Multiple Myeloma 01/2002

Drug/Important Bio-Agent (IBA)

7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 06/2007
3	AutoantibodiesIBA 01/2016 - 11/2005
2	Biomarkers (Surrogate Marker)IBA 01/2015 - 04/2010
2	Etanercept (Enbrel)FDA Link 07/2008 - 12/2007
2	AntibodiesIBA 12/2007 - 11/2005
2	HLA-DR Antigens (HLA-DR)IBA 12/2007 - 11/2005
2	HLA-DRB1 Chains (HLA DRB1)IBA 12/2007 - 09/2002
1	SDMIBA 11/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2023
1	Oxygen (Dioxygen)IBA 10/2020
1	Vitamin D FDA LinkGeneric 01/2020
1	InterleukinsIBA 01/2018
1	Ustekinumab (CNTO 1275)FDA Link 01/2018
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017
1	tocilizumab (atlizumab)FDA Link 01/2017
1	Abatacept (Orencia)FDA Link 01/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2016
1	FibrinIBA 08/2016
1	Antinuclear AntibodiesIBA 01/2015
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 12/2012
1	RNA Polymerase IIIIBA 04/2010
1	Anti-Idiotypic AntibodiesIBA 04/2010
1	Surface Antigens (Surface Antigen)IBA 01/2009
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2009
1	Infliximab (Remicade)FDA Link 12/2007
1	Proteins (Proteins, Gene)FDA Link 12/2007
1	Methotrexate (Mexate)FDA LinkGeneric 06/2007
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 08/2006
1	Pamidronate (Aredia)FDA LinkGeneric 01/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2006
1	Fibrinogen (Factor I)FDA Link 11/2005
1	Staphylococcal Protein A (Protein A)IBA 03/2005
1	CoagulaseIBA 05/2004
1	Immunoglobulin A (IgA)IBA 01/2002

Therapy/Procedure

3	Therapeutics 09/2016 - 12/2007
1	Withholding Treatment 01/2018
1	Biological Therapy 01/2015
1	Surgical Amputation (Amputations) 01/2006
1	Drug Therapy (Chemotherapy) 01/2002